Medical Perfusion Technology Market Size, Share, and Analysis by 2031
Historic Data: 2021-2022 | Base Year: 2021 | Forecast Period: 2024-2031Medical Perfusion Technology Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Hypothermic Machine Perfusion and Normothermic Machine Perfusion), Organ Type (Heart, Lung, Kidney, Liver, and Others), and Component (Perfusion Pumps, Oxygenators, Heart-Lung Machines, Monitoring Systems, Cannulas, and Others), and Geography
- Report Date : Feb 2026
- Report Code : TIPRE00019844
- Category : Life Sciences
- Status : Data Released
- Available Report Formats :

- No. of Pages : 150
The medical perfusion technology market size in 2021 stood at US$ 752.74 million and is projected to reach US$ 1,202.51 million by 2031 from US$ XX million in 2023. The market is expected to register a CAGR of 5.9% in 2023–2031. Perfusion instruments for cell-based research activities, and adoption of compact and portable perfusion machines are likely to remain key medical perfusion technology market trends.
Medical Perfusion Technology Market Analysis
The increasing prevalence of heart diseases such as coronary heart disease, cardiovascular disease, cerebrovascular disease, and rheumatic heart disease, as well as the significant growth of the biotechnology and pharmaceutical companies, the rise in cell-based research activities, and the practice of organ transplantation, all contribute to the growth of the medical perfusion technology market. Also, the well-established healthcare industry, increased investment by key players, and government attempts to develop the healthcare industry are all projected to fuel market growth.
Medical Perfusion Technology Market Overview
The US is projected to be the largest market for medical perfusion technology, the market is attributed due to multiple factors such as increase in cardiovascular disease, comprehensive clinical research, contract research and more. Moreover, in terms of technology, the nation is well ahead of other developed and emerging countries. Advances in technology have resulted in the development of various medical perfusion technologies and technologies that are used for their applications. Heart disease is the number one cause of death in the United States. Coronary heart disease occurs when the heart's arteries are incapable to deliver enough oxygen-rich blood to the heart. According to the CDC, the most frequent type of heart illness is coronary artery disease (CAD), in 2021, ~375,000 people died in the US.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Medical Perfusion Technology Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Medical Perfusion Technology Market Drivers and Opportunities
Rising Prevalence of Cardiovascular Conditions to Favor Market Growth
Cardiovascular diseases (CVDs) are the disorders related to the blood vessels and heart, which includes cerebrovascular disease, rheumatic heart disease, and coronary heart disease (CHD). CVDs are the leading cause of death globally. The structural and functional alteration of vessels are mainly seen in elderly people, which leads to the risk of cardiovascular diseases. According to the Centers of Disease Control and Prevention (CDC) in 2020, heart disease causes death of an estimated 695,000 in the US each year. Moreover, according to the WHO in 2020, globally ~17.9 million people die because of cardiovascular diseases. Moreover, Majority of the CVD deaths are due to the CHD, which is further followed by stroke and heart failure.
Growth Opportunities in Emerging Nations
The emerging regions such as Asia Pacific, Middle East and Africa, and Latin America are growing significantly in the biotechnology and pharmaceutical sectors. The governments in the countries of these regions are supporting through several initiatives, programs, funding, and conferences. The growth of pharmaceutical and biotechnology is driven by the economic and demographic development, rising healthcare expenditures, and improving public-private healthcare funding, among others.
The regions are witnessing a rising number of start-up companies that helps in the production of generic drugs, components of the parts of the medical devices, and others. The R&D activities in the biotechnology and pharmaceuticals sectors are growing. The emerging economies are now seeking support from the developed nations for novel procedures and advanced technologies. Moreover, the well-established players are turning to the emerging nations for their expansions as these regions have enormous potentials to offers market growth.
Medical Perfusion Technology Market Report Segmentation Analysis
Key segments that contributed to the derivation of the medical perfusion technology market analysis are technique, organ type, and component.
- Based on technique, the medical perfusion technology market is bifurcated into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held a larger market share in 2023.
- By organ type, the market is segmented into heart, lung, kidney, liver, and others. The kidney segment held the largest share of the market in 2023.
- In terms of component, the market is divided into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannulas, and others. The oxygenators segment dominated the market in 2023.
Medical Perfusion Technology Market Share Analysis by Geography
The geographic scope of the medical perfusion technology market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the medical perfusion technology market. Increasing adoption of advanced medical perfusion technology, technological advancements and rising emphasis on improving treatment outcomes are projected to accelerate the growth of the medical perfusion technology market. Besides, the rise in the cardiovascular surgeries in Canada, and the increasing prevalence of the cardiovascular and asthma in the Mexico City are likely to boost the growth of medical perfusion technology in the region during the forecast period.
Medical Perfusion Technology Market Regional Insights
The regional trends and factors influencing the Medical Perfusion Technology Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Medical Perfusion Technology Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Medical Perfusion Technology Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 752.74 million |
| Market Size by 2031 | US$ 1,202.51 million |
| Global CAGR (2023 - 2031) | 5.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Technique
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
Medical Perfusion Technology Market Players Density: Understanding Its Impact on Business Dynamics
The Medical Perfusion Technology Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
- Get the Medical Perfusion Technology Market top key players overview
Medical Perfusion Technology Market News and Recent Developments
The medical perfusion technology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for medical perfusion technology:
- XVIVO Perfusion AB completed the acquisition of all shares in the Dutch medtech company Organ Assist B.V. Organ Assist B.V. Organ Assist focuses mainly on developing machines and consumables for perfusion of liver and kidney. Through the acquisition, XVIVO becomes the first company in the world, within the preservation and evaluation of organs, to actively conduct business in all major organ areas. The acquisition accelerates the company's strategy to become a global supplier of solutions and systems in all major organ areas. (Source: XVIVO, Press Release, 2020)
Medical Perfusion Technology Market Report Coverage and Deliverables
The “Medical Perfusion Technology Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Related Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For